Vaccines are responsible for the control of many infectious diseases that were once common in the United States, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German measles), mumps, tetanus, and Haemophilus influenzae type b. National efforts to generate collaboration between federal, state, and local governments and public and private health care providers have resulted in record high levels of vaccination coverage in the United States. The high rate of US vaccinations is paralleled by growing concerns about the safety of their delivery. The variety of substances used in vaccines sometimes causes the development of cutaneous reactions in susceptible adults and children. This article will review adverse cutaneous events consistent with hypersensitivity reactions to the following ingredients in vaccines: aluminum, thimerosal, 2-phenoxyethanol, formaldehyde, and neomycin.
Get full access to this article
View all access options for this article.
References
1.
Physicians' desk reference. 57th ed. Montvale (NJ): Medical Economics; 2003.
2.
MadaanA, MaddoxDE. Vaccine allergy: diagnosis and management. Immunol Allergy Clin North Am, 2003; 23:555-88.
3.
FischerT, RystedtI. A case of contact sensitivity to aluminum. Contact Dermatitis, 1982; 8:343.
4.
TostiA, VincenziC, PelusoAM. Accidental diagnosis of aluminum sensitivity with Finn Chambers. Contact Dermatitis, 1990; 23:48-9.
5.
FrostL, JohansenP, PedersenS, et al.Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy, 1985; 40:368-72.
6.
OffitP, JewR.Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?. Pediatrics, 2003; 112(6 Pt 1):1394-7.
7.
EickhoffTC, MyersM. Conference report: aluminum in vaccines. Vaccine, 2002; 20:S1-4.
8.
HemSL.Elimination of aluminum adjuvants. Vaccine, 2002; 20: S40-3.
9.
Garcia-PatosV, PujolRM, AlomarA, et al.Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol, 1995; 131:1421-4.
10.
FrostL, JohansenP, PedersonS, et al.Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy, 1985; 40:368-72.
11.
OsterballeO.Side effects during immunotherapy with purified grass pollen extracts. Allergy, 1982; 37:553-62.
BrucknerAL, WestonWL, MorelliJG. Does sensitization to contact allergens begin in infancy?. Pediatrics, 2000; 105:1-4.
22.
OsawaJ, KitamuraK, IkezawaZ, NakajimaH. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis, 1991; 24:178-82.
23.
AudicanaMT, MunozD, del PozoMD, et al.Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat, 2002; 13:3-9.
FitzgeraldKA, DaviesA, RussellAD. Mechanism of action of chlorhexidine diacetate and phenoxyethanol singly and in combination against gram-negative bacteria. Microbios, 1992; 70: 215-30.
27.
KomatsuE, YamazakiH, AbeK, et al.Influence of temperature on the efficacy of 2-phenoxyethanol as a preservative for adsorbed diphtheria-purified pertussis-tetanus combined vaccine. J Health Sci, 2002; 48:89-92.
28.
De GrootAC, Van GinkelCJ, WeijlandJW. Methyldibromoglutaronitrile (Euxyl K 400): an important “new” allergen in cosmetics. J Am Acad Dermatol, 1996; 35:743-7.
29.
SassevilleD.Hypersensitivity to preservatives. Dermatol Ther, 2004; 17:251-63.
30.
VogtT, LandthalerM, StolzW. Generalized eczema in an 18-month-old boy due to phenoxyethanol in DPT vaccine. Contact Dermatitis, 1998; 38:50-1.
31.
TilHP, WoutersenRA, FeronVJ, et al.Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol, 1989; 27:77-87.
32.
RingJ.Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet, 1986; 2:522-3.
33.
KwittkenPL, RosenS, SweinbergSK. MMR vaccine and neomycin allergy. Am J Dis Child, 1993; 147:128-9.
34.
Physicians' desk reference. 55th ed. Montvale (NJ): Medical Economics; 2001.
